Lankeit, Mareike <br/><br/>
Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?  [electronic resource] 

 -  Thrombosis research  Dec 2010 
 - e407-8 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2009.10.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Pulmonary Embolism--drug therapy<br/>Risk Factors<br/>Tenecteplase<br/>Tissue Plasminogen Activator--administration & dosage